Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection.
Ludovico Montebianco AbenavoliGiuseppe Guido Maria ScarlataMaria Rosaria ParavatiLuigi BoccutoFrancesco LuzzaEmidio ScarpelliniPublished in: Biomedicines (2023)
Liver transplantation (LT) is the treatment of choice for patients with cirrhosis, decompensated disease, acute liver failure, and hepatocellular carcinoma (HCC). In 3-25% of cases, an alarming problem is acute and chronic cellular rejection after LT, and this event can lead to the need for new transplantation or the death of the patient. On the other hand, gut microbiota is involved in several mechanisms sustaining the model of the "gut-liver axis". These include modulation of the immune response, which is altered in case of gut dysbiosis, possibly resulting in acute graft rejection. Some studies have evaluated the composition of the gut microbiota in cirrhotic patients before and after LT, but few of them have assessed its impact on liver rejection. This review underlines the changes in gut microbiota composition before and after liver transplantation, hypothesizing possible immune mechanisms linking dysbiosis to transplantation rejection. Evaluation of changes in the gut microbiota composition in these patients is therefore essential in order to monitor the success of LT and eventually adopt appropriate preventive measures.
Keyphrases
- liver failure
- end stage renal disease
- hepatitis b virus
- ejection fraction
- immune response
- chronic kidney disease
- newly diagnosed
- drug induced
- respiratory failure
- heart failure
- prognostic factors
- stem cells
- toll like receptor
- intensive care unit
- atrial fibrillation
- inflammatory response
- mechanical ventilation
- extracorporeal membrane oxygenation
- dendritic cells
- acute respiratory distress syndrome
- case control